In vitro assessment of the allergenicity of a novel influenza vaccine produced in dog kidney cells in individuals with dog allergy

Annals of Allergy, Asthma and Immunology

Volumn 104, Issue 5, 2010, Pages 426-433

  Wanich, Niya ^a   Bencharitiwong, Ramon ^a   Tsai, Theodore ^b   Nowak Wegrzyn, Anna ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Novartis Vaccines Cambridge   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EGG PROTEIN; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN E RECEPTOR; INFLUENZA VACCINE;

ADOLESCENT; ADULT; ALLERGENICITY; ALLERGY; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHICK EMBRYO; CONTROL GROUP; CONTROLLED STUDY; DEGRANULATION; EMBRYO; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; KIDNEY CELL; MALE; NONHUMAN; PRICK TEST; PRIORITY JOURNAL; PROTEIN ELECTROPHORESIS; RAT; SKIN TEST; WESTERN BLOTTING;

ADULT; ALLERGENS; ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODY SPECIFICITY; BLOTTING, WESTERN; CELL DEGRANULATION; CELL LINE; CELL LINE, TRANSFORMED; DOGS; FEMALE; HUMANS; HYPERSENSITIVITY; INFLUENZA VACCINES; MALE; MIDDLE AGED; RATS; VACCINES, INACTIVATED;

EID: 77953142014     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2010.03.012     Document Type: Article

References (46)

1. Glezen W.P. Clinical practice: prevention and treatment of seasonal influenza. N Engl J Med 359 (2008) 2579-2585
2. Bridges C.B., Katz J.M., Levankowski R.A., and Cox N.J. Inactivated influenza vaccines. In: Plotkin S.A., Orenstein W.A., and Offitt P.A. (Eds). Vaccines. 5th ed. (2008), WB Saunders Co, Philadelphia, PA 259-290
3. Poehling K.A., Edwards K.M., Weinberg G.A., et al. The underrecognized burden of influenza in young children. N Eng J Med 355 (2006) 31-40
4. Fiore A.E., Shay D.K., Broder K., et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 58 (2009) 1-52
5. Jain S., Kamimoto L., Bramley A.M., et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 361 (2009) 1935-1944
6. Finelli L., Brammer L., Kniss K., et al. Influenza Epidemiology and Surveillance. CDC Website. http://www.cdc.gov/vaccines/recs/acip/downloads/mtg-slides-oct09/12-2-flu-vac.pdf Accessed November 1, 2009
7. Kelso J.M., Li J.T., Nicklas R.A., et al. Adverse reactions to vaccines. Ann Allergy Asthma Immunol 103 suppl 2 (2009) S1-S14
8. O'Brien T.C., Maloney C., and Tauraso N.M. Quantitation of residual host protein in chicken embryo-derived vaccines by radial immunodiffusion. Appl Microbiol 21 (1971) 780-782
9. Miller J.R., Orgel H.A., and Meltzer E.O. The safety of egg-containing vaccines for egg-allergic patients. J Allergy Clin Immunol 71 (1983) 568-573
10. Murphy K.R., and Strunk R.C. Safe administration of influenza vaccine in asthmatic children hypersensitive to egg proteins. J Pediatr 106 (1995) 931-933
11. James J.M., Zeiger R.S., Lestor M.R., et al. Safe administration of influenza vaccine to patients with egg allergy. J Pediatr 133 (1998) 624-628
12. Ratner B., and Untracht S. Allergy to virus and rickettsial vaccines, I: allergy to influenza A and B vaccines in children. JAMA 132 (1946) 899-905
13. Bierman C.W., Shapiro G.G., Pierson W.E., Taylor J.W., Foy H.M., and Fox J.I. Safety of influenza vaccination in allergic children. J Infect Dis 136 (1977) S68-S73
14. Davies R., and Pepys J. Egg allergy, influenza vaccine, and immunoglobulin E antibody. J Allergy Clin Immunol 57 (1976) 373-383
15. Kawahara H., Morisawa Y., Katunuma T., Ohya Y., Saito H., and Akasawa A. Immediate adverse reactions after administration of the influenza vaccine to patients with positive CAP-RAST to egg white. Arerugi 51 (2002) 559-564
16. Bierman C.W., Shapiro G.G., Pierson W.E., Taylor J.W., Foy H.M., and Fox J.P. Safety of influenza vaccination in allergic children. J Infect Dis 136 (1977) S652-S655
17. Multanowska A., Szymczakiewicz-Multanowska A., Groth N., et al. Safety and immunogenicity of a novel influenza subunit vaccine produced in mammalian cell culture. J Infect Dis 200 (2009) 841-848
18. Reisinger K.S., Block S.L., Izu A., Groth N., and Holmes S.J. Subunit influenza vaccines produced from cell culture or in embryonated chicken-eggs: comparison of safety, reactogenicity, and immunogenicity. J Infect Dis 200 (2009) 849-857
19. Groth N., Montomoli E., Gentile C., Manini I., Bugarini R., and Podda A. Safety, tolerability and immunogenicity of a mammalian cell-culture-derived influenza vaccine: a sequential Phase I and Phase II clinical trial. Vaccine 27 (2009) 786-791
20. Vogel L., Luttkopf D., Hatahet L., Haustein D., and Vieths S. Development of a functional in vitro assay as a novel tool for the standardization of allergen extracts in the human system. Allergy 60 (2005) 1021-1028
21. Hoffmann A., Vogel L., Scheurer S., Vieths S., and Haustein D. Potency determination of allergenic extracts using mediator release of rat basophil leukemia cells. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M 91 (1997) 203-208
22. Kaul S., Luttkopf D., Kastner B., et al. Mediator release assays based on human or murine immunoglobulin E in allergen standardization. Clin Exp Allergy 371 (2007) 141-150
23. Hoffmann A., Jamin A., Foetisch K., et al. Determination of the allergenic activity of birch pollen and apple prick test solutions by measurement of β-hexosaminidase release from RBL-2H3 cells: comparison with classical methods in allergen standardization. Allergy 545 (1999) 446-454
24. King N., Helm R., Stanley J.S., et al. Allergenic characteristics of a modified peanut allergen. Mol Nutr Food Res 4910 (2005) 963-971
25. Bolhaar S.T., Zuidmeer L., Ma Y., et al. A mutant of the major apple allergen, Mal d 1, demonstrating hypo-allergenicity in the target organ by double-blind placebo-controlled food challenge. Clin Exp Allergy 35 (2005) 1638-1644
26. Sicherer S.H., Noone S.A., Koerner C.B., Christie L., Burks A.W., and Sampson H.A. Hypoallergenicity and efficacy of an amino acid-based formula in children with cow's milk and multiple food hypersensitivities. J Pediatr 138 (2001) 688-693
27. Izurieta H.S., Thompson W.W., Kramarz P., et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 342 (2000) 232-239
28. Neuzil K.M., Mellen B.G., Wright P.F., Mitchel Jr. E.F., and Griffin M.R. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 342 (2000) 225-231
29. Bhat N., Wright J.G., Broder K.R., et al. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med 353 (2005) 2559-2567
30. Shannon S., Louie J., Siniscalchi A., et al. Surveillance for pediatric deaths associated with 2009 pandemic influenza A(H1N1) virus infection-United States, April-August 2009. MMWR Morb Mortal Wkly Rep 58 (2009) 941-947
31. Seasonal influenza (flu). CDC Website. http://www.cdc.gov/flu/weekly/ Accessed November 1, 2009
32. Sampson H.A., and McCaskill C.C. Food hypersensitivity and atopic dermatitis: evaluation of 113 patients. J Pediatr 107 (1985) 669-675
33. Bock S.A., and Atkins F.M. Patterns of food hypersensitivity during sixteen years of double-blind, placebo-controlled food challenges. J Pediatr 117 (1990) 561-567
34. Bock S.A., Sampson H.A., Atkins F.M., et al. Double-blind, placebo-controlled food challenge (DBPCFC) as an office procedure: a manual. J Allergy Clin Immunol 82 (1988) 986-997
35. Eggesbo M., Botten G., Halvorsen R., and Magnus P. The prevalence of allergy to egg: a population-based study in young children. Allergy 56 (2001) 403-411
36. Osterballe M., Hansen T.K., Mortz C.G., et al. The prevalence of food hypersensitivity in an unselected population of children and adults. Pediatr Allergy Immunol 16 (2005) 567-573
37. Demicheli V., Jefferson T., Rivetti D., and Deeks J. Prevention and early treatment of influenza in healthy adults. Vaccine 18 (2000) 957-1030
38. Cooper N.J., Sutton A.J., Abrams K.R., et al. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials. BMJ 326 (2003) 1235
39. Jefferson T., Demicheli V., Deeks J., et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults. Cochrane Database Syst Rev 3 (2000) CD001265
40. Wright P.F. Does oseltamivir work against influenza B?. Clin Infect Dis 44 (2007) 203
41. Sugaya N., Mitamura K., Yamazki M., et al. Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children. Clin Infect Dis 44 (2007) 197-202
42. Kawai N., Ikematsu H., Iwaki N., et al. A comparison of the effectiveness of oseltamivir for the treatment of influenza A and influenza B: a Japanese multicenter study of the 2003-2004 and 2004-2005 influenza seasons. Clin Infect Dis 43 (2006) 439-444
43. Dharan N.J., Gubareva L.V., Meyer J.J., et al., Oseltamivir-Resistance Working Group. Infections with oseltamivir-resistant influenza A (H1N1) virus in the United States. JAMA 301 (2009) 1034-1041
44. Moscona A. Global transmission of oseltamivir-resistant influenza. N Engl J Med 360 (2009) 953-956
45. H1N1 flu. CDC Website. http://www.cdc.gov/h1n1flu/update.htm Accessed June 12, 2009
46. US Department of Health and Human Services. Guidance on allocating and targeting pandemic influenza vaccine. http://www.pandemicflu.gov/vaccine/allocationguidance.pdf Accessed June 12, 2009